Clinical Trials Directory

Trials / Completed

CompletedNCT02011516

Baclofen Effects on Marijuana Dependence

A Randomized Placebo-controlled Study of Baclofen on Brain and Behavioral Outcomes in Marijuana Dependence

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
47 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Studies show that certain reminders of drug use such as the sight of someone using marijuana, pictures of blunts, particular moments throughout the day, prompt marijuana users to smoke marijuana. We are measuring the brain and behavioral responses of marijuana dependent individuals to these reminders (cues) We will examine brain responses during cue exposure and determine whether these responses are associated with treatment outcome. We are testing the hypothesis that the medication baclofen reduces brain responses during marijuana cue exposure and/or craving in marijuana dependent individuals. Baclofen is FDA-approved for other uses, but not for the treatment of marijuana dependence. Functional magnetic resonance imaging (fMRI) will be used to measure the brain's response to marijuana cues. fMRI is a painless technique that takes special pictures of the brain (or other parts of your body). It does not involve radiation or injections. Eligible participants will have a 50% chance of receiving placebo (sugar pill) and a 50% chance of receiving baclofen. Neither the participant nor study personnel will know whether participants are receiving baclofen or placebo. Participants will also receive twice weekly psychosocial treatment with a certified clinician. Twelve weeks of treatment will be followed by a 12 week follow up.

Conditions

Interventions

TypeNameDescription
DRUGBaclofen
BEHAVIORALPsychosocial
DRUGPlacebo

Timeline

Start date
2013-12-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-12-13
Last updated
2017-06-14
Results posted
2017-06-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02011516. Inclusion in this directory is not an endorsement.